SEPTEMBER, 2014 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,846,385 | Method and means for producing high titer, safe recombinant lentivirus vectors | Algenol Biofuels Inc. | 30-Sep-14 | United States |
8,835,153 | Process and genes for expression and overexpression of active [FeFe] hydrogenases | Alliance for Sustainable Energy, LLC | 16-Sep-14 | United States |
8,822,166 | Stimulus-elicited genomic profile markers of alzheimer's disease | Blanchette Rockefeller Neurosciences Institute | 2-Sep-14 | United States |
8,828,687 | Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions | Bonaldo; Myrna Cristina | 9-Sep-14 | Brazil |
8,828,718 | Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements | Centre National de la Recherche Scientifique | 9-Sep-14 | France |
8,835,105 | Sperm-specific cation channel, CatSper4, and uses therefor | Children's Medical Center Corporation | 16-Sep-14 | United States |
8,835,154 | Microorganism having enhanced L-amino acids productivity and process for producing L-amino acids using the same | CJ Cheiljedang Corporation | 16-Sep-14 | Korea |
8,846,367 | Coryneform bacterium transformant and process for producing phenol using the same | Danisco US Inc. | 30-Sep-14 | United States |
8,841,088 | Method for mRNA stabilization | DSM IP Assets B.V. | 23-Sep-14 | Netherlands |
8,822,185 | Peroxisome biogenesis factor protein (PEX) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms | E I du Pont de Nemours and Company | 2-Sep-14 | United States |
8,822,222 | Apparatus for generating electrical pulses and methods of using same | Eastern Virginia Medical School | 2-Sep-14 | United States |
8,835,106 | Method for typing and detecting HBV | Fujirebio Europe N.V. | 16-Sep-14 | Belogium |
8,846,387 | Targeted gene modification by parvoviral vectors | GBP IP, LLC | 30-Sep-14 | United States |
8,846,369 | Cyanobacterium sp. host cell and vector for production of chemical compounds in cyanobacterial cultures | Green Phenol Development Co., Ltd. | 30-Sep-14 | Japan |
8,828,662 | Method and kit for detection of microsatellite instability-positive cell | Hitachi, Ltd. | 9-Sep-14 | Japan |
8,828,686 | Polynucleotides encoding therapeutic inhibitors of PAI-1 | Intrexon Corporation | 9-Sep-14 | United States |
8,828,699 | Eukaryotic amadoriase, gene and recombinant DNA for the eukaryotic amadoriase, and process for production of the eukaryotic amadoriase | Kikkoman Corporation | 9-Sep-14 | Japan |
8,835,147 | Cellular production of glucaric acid through recombinant expression of uronate dehydrogenase and myo-inositol oxygenase | Massachusetts Institute of Technology | 16-Sep-14 | United States |
8,841,094 | Homologous recombination method, cloning method, and kit | National University Corporation University of Toyama | 23-Sep-14 | Japan |
8,846,318 | Method for identifying olfactory receptor included in one olfactory cell | Panasonic Corporation | 30-Sep-14 | Japan |
8,841,074 | MPL mutations in JAK2 V617F negative patients with myeloproliferative disease | Quest Diagnostics Investments Incorporated | 23-Sep-14 | United States |
8,846,402 | Method for genetically modifying isolated non-human mammalian cell by homologous recombination | Regeneron Pharmaceuticals, Inc. | 30-Sep-14 | United States |
8,822,180 | Method of synthesizing a suppressor tRNA, DNA construct and use thereof for producing a non-natural amino acid-incorporated protein | Riken | 2-Sep-14 | Japan |
8,846,364 | Method to improve the stability and broaden the pH range of family G/11 xylanases | Sharp Kabushiki Kaisha | 30-Sep-14 | Japan |
8,841,126 | Method for gene transfer | Takara Bio Inc. | 23-Sep-14 | Japan |
8,835,177 | Method for transfer of gene into fat cell or progenitor fat cell | Takara Bio Inc. | 16-Sep-14 | Japan |
8,822,155 | Quantitative multiplex methylation-specific PCR | The Johns Hopkins University | 2-Sep-14 | United States |
8,828,652 | Elimination of N-glycolylneuraminic acid from animal products for human use | The Regents of the University of California | 9-Sep-14 | United States |
8,822,216 | DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof | The Trustees of Columbia University in the City of New York | 2-Sep-14 | United States |
8,822,153 | Molecular diagnosis and typing of lung cancer variants | The University of North Carolina at Chapel Hill | 2-Sep-14 | United States |
8,846,396 | Methods for the isolation of cardiac stem cells | The University of Washington | 30-Sep-14 | United States |
8,828,693 | Method for producing isopropanol and recombinant yeast capable of producing isopropanol | Toyora Jidosha Kabushiki Kaisha | 9-Sep-14 | Japan |
8,846,398 | Method for preparing human neoplastically transformed cells | Universita Degli Studi Di Roma "La Sapienza" | 30-Sep-14 | Italy |
8,846,358 | Method and device for producing hydrogen | Yamaguchi University | 30-Sep-14 | Japan |
8,846,343 | High-expression promoter derived from Kluyveromyces marxianus | Yamaguchi University | 30-Sep-14 | Japan |
8,846,315 | Disease risk factors and methods of use | Zinfandel Pharmaceuticals, Inc. | 30-Sep-14 | United States |
COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,846,578 | Zinc finger nuclease for the CFTR gene and methods of use thereof | The General Hospital Corporation | 30-Sep-14 | United States |
8,846,577 | Phage display using cotranslational translocation of fusion polypeptides | University of Zurich | 30-Sep-14 | Switzerland |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,849,576 | Phylogenetic analysis of mass spectrometry or gene array data for the diagnosis of physiological conditions | Amri; Hakima | 30-Sep-14 | United States |
8,843,320 | Use of gene expression profiling to predict survival in cancer patient | Board of Trustees of the University of Arkansas | 23-Sep-14 | United States |
8,831,890 | System and method for determining individualized medical intervention for a disease state | Caris MPI, Inc. | 9-Sep-14 | United States |
8,825,560 | Distributed evolutionary algorithm for asset management and trading | Genetic Finance (Barbados) Limited | 2-Sep-14 | Barbadose |
8,843,356 | Computer systems and methods for associating genes with traits using cross species data | Merck Sharp & Dohme Corp. | 23-Sep-14 | United States |
8,832,581 | Gene expression browser for web-based search and visualization of characteristics of gene expression | Zhang; Ming | 9-Sep-14 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,828,964 | Cancer cell identification marker and cancer cell proliferation inhibitor | Accural Inc. | 9-Sep-14 | Japan |
8,846,043 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Agensys, Inc. | 30-Sep-14 | United States |
8,821,869 | Treatment methods using c-Met antibodies | Amgen Fremont Inc. | 2-Sep-14 | United States |
8,828,456 | Method of external skin application of composition containing red pine root extract | Amorepacific Corporation | 9-Sep-14 | Korea |
8,828,934 | Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism | Boehringer Ingelheim International GmbH | 9-Sep-14 | Germany |
8,821,856 | Method of targeted gene delivery using viral vectors | California Institute of Technology | 2-Sep-14 | United States |
8,835,480 | Inhibitors for steroid response elements and related methods | California Institute of Technology | 16-Sep-14 | United States |
8,828,939 | Modified vitamin K dependent polypeptides | CSL Behring GmbH | 9-Sep-14 | Germany |
8,841,267 | Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs | GE Healthcare Dharmacon, Inc. | 23-Sep-14 | United States |
8,828,959 | Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells | Gene Signal International SA | 9-Sep-14 | Switzerland |
8,821,892 | Yeast-based therapeutic for chronic hepatitis C infection | GlobeImmune, Inc. | 2-Sep-14 | United States |
8,828,406 | Influenza viruses and uses thereof | Icahn School of Medicine at Mount Sinai | 9-Sep-14 | United States |
8,821,862 | Soluble .beta.-N-acetylglucosaminidase based antibiofilm compositions and uses thereof | Kane Biotech Inc. | 2-Sep-14 | United States |
8,841,272 | Double-stranded RNA-based nanoparticles for insect gene silencing | Kansas State University Research Foundation | 23-Sep-14 | United States |
8,846,630 | Pharmaceutical composition for treating cancer | Korea Research Institute of Bioscience and Biotechnology | 30-Sep-14 | Korea |
8,846,625 | Glucagon-like peptide-2 analogs | NPS Pharmaceuticals, Inc. | 30-Sep-14 | United States |
8,828,356 | Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis | Progeria Research Foundation, Inc. | 9-Sep-14 | United States |
8,841,268 | Method and kit for detection of cancer, and therapeutic agent for cancer | Sapporo Medical University | 23-Sep-14 | Japan |
8,828,958 | Single-stranded antimicrobial oligonucleotides and uses thereof | Star Biologics, Inc. | 9-Sep-14 | United States |
RE45,170 | Streptococcus suis vaccines and diagnostic tests | Stichting Dienst Landbouwkundig Onderzoek | 30-Sep-14 | Netherlands |
8,846,629 | Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma | The Regents of the University of California | 30-Sep-14 | United States |
8,834,863 | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof | The Trustees of the University of Pennsylvania | 16-Sep-14 | United States |
8,846,031 | Simian adenovirus 41 and uses thereof | The Trustees of the University of Pennsylvania | 30-Sep-14 | United States |
8,822,540 | Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation | The United States of America, as represented by the Secretary, Department of Health and Human Services | 2-Sep-14 | United States |
8,828,378 | Targeted vectors for cancer immunotherapy | The University of Southern California | 9-Sep-14 | United States |
8,828,954 | Use for scopolin and derivatives thereof | Yonsei University Technology Holdings, Inc. | 9-Sep-14 | Korea |
ETCHING A SUBSTRATE: PROCESSES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,828,246 | Method of fabricating micro-devices | Anpac Bio-Medical Science Co., Ltd. | 9-Sep-14 | British Virgin Islands |
IMAGE ANALYSIS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,848,988 | Appliance and method for evaluation and assessment of a test strip | Optricon GmbH | 30-Sep-14 | Germany |
INFORMATION SECURITY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,832,808 | Cyber gene identification technology based on entity features in cyber space | Liu; Nanjie | 9-Sep-14 | China P Rep |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,829,272 | Specific expression using transcriptional control sequences in plants | Adelaide Research & Innovation Pty Ltd | 9-Sep-14 | Australia |
8,835,715 | Plants expressing .DELTA.6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids | BASF Plant Science GmbH | 16-Sep-14 | Germany |
8,847,018 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 30-Sep-14 | Germany |
8,847,017 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 30-Sep-14 | Germany |
8,829,264 | Methods and compositions for RNA interference | Cold Spring Harbor Laboratory | 9-Sep-14 | United States |
8,822,754 | Ecdysone receptor-based inducible gene expression system | Intrexon Corporation | 2-Sep-14 | United States |
8,829,275 | Methods and compositions for obtaining marker-free transgenic plants | Monsanto Technology LLC | 9-Sep-14 | United States |
8,841,508 | Non-human mammalian animal model for type 2 diabetes | National University Corporation | 23-Sep-14 | Japan |
8,829,315 | Wheat with altered branching enzyme activity and starch containing products derived therefrom | Commonwealth Scientific and Industrial Research Organisation | 9-Sep-14 | Australia |
8,822,758 | Gene capable of increasing the production of plant biomass and method for using the same | Toyota Jidosha Kabushiki Kaisha | 2-Sep-14 | Japan |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,822,646 | Cancer therapies and pharmaceutical compositions used therein | ProNAi Therapeutics, Inc. | 2-Sep-14 | United States |
8,841,423 | Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II | University of Iowa Research Foundation | 23-Sep-14 | United States |
8,835,618 | Mutations of the parkin gene | Aventis Pharma S.A. | 16-Sep-14 | France |
8,835,622 | Expression cassettes for seed-specific expression in plants | Bayer BioScience N.V. | 16-Sep-14 | Belgium |
8,846,884 | Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elements | Baylor College of Medicine | 30-Sep-14 | Germany |
8,835,621 | Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression | Intrexon Corporation | 16-Sep-14 | United States |
8,829,169 | Assay for imidazolinone resistance mutations in Brassica species | Monsanto Canada Inc. | 9-Sep-14 | Canada |
8,835,623 | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc | 16-Sep-14 | United States |
8,846,894 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc | 30-Sep-14 | United States |
8,841,432 | Shuttle vectors for mycobacteria-escherichia coli and uses thereof | SNU R&DB Foundation | 23-Sep-14 | Korea |
8,835,108 | RNA containing modified nucleosides and methods of use thereof | The Trustees of the University of Pennsylvania | 16-Sep-14 | United States |
8,846,889 | Peptide biosynthesis and pain therapy | Wolfe; Darren P. | 30-Sep-14 | United States |
SYNTHETIC RESINS OR NATURAL RUBBERS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,846,850 | Amphiphilic macromolecules for nucleic acid delivery | Rutgers, the State University of New Jersey | 30-Sep-14 | United States |
8,829,109 | Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery | University of Utah Research Foundation | 9-Sep-14 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.